Drugs | Isolate IC50 | Ratio IC50 Isolate/W2 | W2* IC50 | Isolates** Mean IC50 (CI95%) | Ratio IC50 Isolates/W2 | Resistance cut-off |
---|---|---|---|---|---|---|
Dihydroartemisinin | 21.2 nM | 11.8 | 1.8 nM | 2.2 nM (1.3-3.7) | 1.2 | > 10.5 nM |
Artesunate | 16.3 nM | 10.2 | 1.6 nM | 1.9 nM (1.0-3.2) | 1.2 | > 10.5 nM |
Quinine | 1131 nM | 1.5 | 731 nM | 201 nM (131-307) | 0.3 | > 800 nM |
Mefloquine | 166 nM | 4.5 | 36.6 nM | 26.0 nM (15.9-42.5) | 0.7 | > 30 nM |
Lumefantrine | 114 nM | 4.0 | 28.4 nM | 23.9 nM (14.1-40.8) | 0.8 | > 150 nM |
Pyronaridine | 70.5 nM | 7.8 | 9.0 nM | 26.2 nM (15.4-44.6) | 2.9 | ND |
Piperaquine | 91.1 nM | 3.3 | 27.3 nM | 66.2 nM (34.7-126.3) | 2.4 | ND |
Chloroquine | 63 nM | 0.14 | 449 nM | 63 nM (29-138) | 0.1 | > 100 nM |
Monodesethylamodiaquine | 34.4 nM | 0.54 | 63.2 nM | 32.4 nM (19.2-54.8) | 0.5 | > 80 nM |
Atovaquone | 2.21 nM | 0.74 | 2.99 nM | 1.48 nM (1.06-2.07) | 0.5 | > 490 nM |
Doxycycline | 18.5 μM | 1.5 | 12.1 μM | 10.0 μM (7.8-12.9) | 0.8 | > 35 μM |
Pyrimethamine | 497 nM | 0.04 | 12621 nM | 107 nM (7-1681) | 0.01 | > 2000 nM |